期刊文献+

体外鉴定的禽流感病毒T细胞表位的免疫效果研究 被引量:1

The Immunologic Effect of Identified Avian Influenza Viruses T Cell Epitopes in vitro
下载PDF
导出
摘要 为验证来源于禽流感病毒的、可与鸡MHCⅠ类分子结合的九肽KILTIYSTV和LLLAIVSLV的免疫原性,使用TIGECPKYV、LLLAIVSLV和KILTIYSTV 3条多肽免疫BALB/c小鼠,加强免疫时和加强免疫1、2、3、4、5周后分别采血,流式细胞术测定免疫前后小鼠外周抗凝血中CD8+淋巴细胞的变化情况;加强免疫后14 d进行MTT试验;首次免疫3周后进行DTH试验;ELISA检测免疫前后小鼠分泌IFN-γ的变化情况。结果表明,KILT-IYSTV、LLLAIVSLV、TIGECPKYV免疫后分别引起CD8+T淋巴细胞4.2%、4.0%和0.2%的额外增殖。KILTIYSTV和LLLAIVSLV免疫组的IFN-γ的增长和迟发型变态反应均显著高于对照组。简言之,与重建的MHCⅠ类分子结合的多肽KILTIYSTV和LLLAIVSLV可以刺激小鼠产生特异性CTL反应,而不结合的多肽TIGECPKYV刺激小鼠未产生特异性CTL反应。 To identify whether avian influenza viruses (AIV) derived peptides KILTIYSTV and LLLAIVSLV are authentic T cell epitopes, 6 weeks old BALB/c mice were immunized with KILTIYSTV, LLLAIVSLV and KILTIYSTV respectively. The blood samples were collected at the 1st, 2nd, 3rd, 4th and 5th week after reimmunization. CD8^+ T cell was detected by fluorescence activated cell sorting (FACS). MTT test was carried out at 14 days after boost immunization; Peptide-specific delayed-type of hypersensitivity assay was done on third weeks after the first immunization. Proliferation of secreted IFN-γ in serum of mice was detected by ELISA. The results showed that the peptides KILTIYSTV, LLLAIVSLV and TIGECPKYV stimulated 4.2%, 4.0% and 0.2% growth of peptide-specific CD8^+ T lymphocyte, Secreted IFN-γ level, specific delayed-type of hypersensitivity (DTH) response and MTT test in KILTIYSTV and LLLAIVSLV group were all significantly higher than that of control groups. In a word, animal immunity experiment revealed that two T cell epitopes KILTIYSTV and LLLAIVSLV could lead to specified CTL reaction, but the peptide TIGECPKYV that don't bind with reconstructed MHC Ⅰ couldn't.
出处 《畜牧兽医学报》 CAS CSCD 北大核心 2008年第4期460-465,共6页 ACTA VETERINARIA ET ZOOTECHNICA SINICA
基金 国家自然科学基金资助项目(30371098)
关键词 多肽 免疫 禽流感病毒 CTL peptide immunization avian influenza virus cytotoxic lymphocyte (CTL)
  • 相关文献

参考文献16

  • 1CORR M, SLANETZ A E, BOYD L F, et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity [J]. Science, 1994, 265:946- 949.
  • 2EGGERS M, BOES-FABIAN B, RUPPERT T, et al. The cleavage preference of the proteasome governs the yield of antigenic peptides [J]. J Exp Med, 1995, 182:1 865-1 870.
  • 3EISENLOHR L C, BACIK I, BENNINK J R, et al. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes [J]. Cell, 1992,71 : 963-972.
  • 4李新生,陈红英,闫若潜,高凤山,方勤美,夏春.禽流感病毒T细胞表位与体外重建鸡MHCⅠ类分子结合试验[J].畜牧兽医学报,2007,38(12):1335-1340. 被引量:13
  • 5VITHAYASAI V, SIRISANTHANA T, SAKONWASUN C, et al. Flow cytometric analysis of T-lymphocytes subsets in adult Thais [J]. Asian Pac J Allergy Immunol, 1997,15 : 141-146.
  • 6YOUNG H A, HARDY K J. Role of interferon-gamma in immune cell regulation [J]. J Leukoc Biol, 1995,58:373-381.
  • 7WENNER C A, GULER M L, MACATONIA S E, et al. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development [J]. J Immunol, 1996,156:1 442-1 447.
  • 8MAGRAM J, CONNAUGHTON S E, WARRIER R R, et al. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses [J]. Immunity ,1996,4 :471-481.
  • 9KIM A, NOH Y W, KIM K D, et al. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination [J]. Exp Mol Med,2004,36:428-443.
  • 10NINOMIYA A, OGASAWARA K, KAJINO K, et al. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice [J]. Vaccine, 2002, 20: 3 123-3 129.

二级参考文献16

  • 1李新生,闫若潜,高风山,方勤美,郝惠芳,李云岗,陈红英,夏春.重叠延伸PCR法体外重建鸡主要组织相容性复合体Ⅰ[J].畜牧兽医学报,2006,37(10):1047-1052. 被引量:2
  • 2Tsunoda T. Development for a novel cancer vaccine [J]. Gan To Kagaku Ryoho,2004,31:2 095-2 099.
  • 3Ogasawara K, Onoe K. MHC-binding motifs and the design of peptide-based vaccines [J]. Trends Microbiol,1993,1:276-279.
  • 4Polakova K, Plaksin D, Chung D H, et al. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity[J].J Immunol,2000,165:5 703-5 712.
  • 5Sugawara S, Abo T, Kumagai K. A simple method to eliminate the antigenicity of surface class I MHC molecules from the membrane of viable cells by acid treatment at pH3 [J]. J Immunol Methods, 1987, 100:83-90.
  • 6Storkus W J, Zeh H J, Maeurer M J, et al. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes [J].J Immunol,1993,151:3 719-3 727.
  • 7Kikuchi T, Uehara S, Ariga H, etal. Augmented in- duction of CD8^+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide [J]. Immunology, 2006,117:47-58
  • 8Reed-Loisel L M, Sullivan B A, Laur O, et al. An MHC class Ib-restricted TCR that cross-reacts with an MHC class Ia molecule [J]. J Immunol, 2005, 174:7 746-7 752
  • 9Moorthy V S, Imoukhuede E B, Keating S, et al. Phase 1 evaluation of 3 highly immunogenic primeboost regimens, including a 12-month reboosting vac- cination, for malaria vaccination in Gambian men [J].J Infect Dis,2004,189:2 213-2 219.
  • 10Fremont D H, Matsumura M, Stura E A, et al.Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb [J]. Science, 1992,257:919-927.

共引文献12

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部